Article references (16 references )

  1. Bell JS, Blacker N, Leblanc VT, Alderman CP, Phillips A, Rowett D et al. Prescribing for older people with chronic renal impairment. Aust Fam Physician. 2013; 42(1-2):24-28. PubMed | Google Scholar

  2. Corsonello A, Pedone C, Corica F, Mussi C, Carbonin P, Antonelli IR et al. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients: concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med. 2005; 165(7):790-795. PubMed | Google Scholar

  3. Pharmaceutical Care Network Europe (PCNE) Foundation. The PCNE classification scheme for drug related problems V 62. 2010. Accessed on 30 Oct 2016.

  4. Akici A, Oktay S. Rational pharmacotherapy and pharmacovigilance. Curr Drug Saf. 2007; 2(1):65-69. PubMed | Google Scholar

  5. Meyboom RH, Lindquist M, Egberts AC. An ABC of drug-related problems. Drug Safety. 2000 Jun; 22 (6): 415-423. PubMed | Google Scholar

  6. KDOQI, National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. AmJKidney Dis. 2006; 47(5 Suppl 3):S11-145. Google Scholar

  7. Kidney Disease Improving Global Outcomes (KDIGO). KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2012; 2(5):1-150. Google Scholar

  8. Marquito AB, Fernandes NM, Colugnati FA, de Paula RB. Identifying potential drug interactions in chronic kidney disease patients. J BrasNefrol. 2014; 36(1):26-34. PubMed | Google Scholar

  9. Rama M, Viswanathan G, Acharya LD, Attur RP, Reddy PN, Raghavan SV. Assessment of drug-drug interactions among renal failure patients of nephrology ward in a South Indian tertiary care hospital. Indian J Pharm Sci. 2012; 74(1):63-68. PubMed | Google Scholar

  10. Bastos MG. Drug-drug interaction. J BrasNefrol. 2014; 36(1):8-9. PubMed | Google Scholar

  11. Omudhome Ogbru, Jay W Marks. Drug interactions checker . 2010. Accessed on 30 Oct 2016.

  12. Michigan Medicine, Univsersity of Michigan. Management of Chronic Kidney Disease. March 2014. Accessed on 29 Oct 2016.

  13. Ghanbari Y, Nagaraju K. Identifying drug-drug interaction among chronic kidney disease patients in tertiary care hospital. International Research Journal of Pharmacy. 2016; 7(7):54-56. Google Scholar

  14. Al-Ramahi R, Raddad AR, Rashed AO, Bsharat A, Abu-Ghazaleh DA, Yasin E et al. Evaluation of potential drug-drug interactions among Palestinian hemodialysis patients. BMC Nephrol. 2016; 17:96. PubMed | Google Scholar

  15. Thomas R, Kanso A, Sedor JR. Chronic kidney disease and its complications. Prim Care. 2008; 35(2):329-vii. PubMed | Google Scholar

  16. Merlo J, Liedholm H, Lindblad U, Björck-Linné A, Fält J, Lindberg G et al. Prescriptions with potential drug interactions dispensed at Swedish pharmacies in January 1999: cross sectional study. BMJ. 2001; 323(7310):427-428. PubMed | Google Scholar